CRMD Q1 2017 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$518M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$39,559-4.5% YoY

Gross Profit

-$54,012-136.5% margin

Operating Income

-$8M-19259.9% margin

Net Income

-$8M-19203.9% margin

EPS (Diluted)

$-0.93

QoQ Revenue Growth

-67.5%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$452,023

Balance Sheet

Total Assets

$15M

Total Liabilities

$4M

Stockholders' Equity

$11M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$39,559	$41,427	-4.5%
Gross Profit	-$54,012	-$8,802	-513.6%
Operating Income	-$8M	-$4M	-78.8%
Net Income	-$8M	-$4M	-79.5%